Name: Formulating Poorly Water Soluble Drugs (en Inglés)
Price: 383.47 USD
Availability: InStock
Author: Williams III, Robert O. ; Davis Jr, Daniel A. ; Miller, Dave A.
ISBN: 9783030887186

portada Formulating Poorly Water Soluble Drugs (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Williams III, Robert O. ; Davis Jr, Daniel A. ; Miller, Dave A.

Idioma

Inglés

N° páginas

693

Encuadernación

Tapa Dura

Dimensiones

25.4 x 17.8 x 3.8 cm

Peso

1.43 kg.

ISBN13

9783030887186

N° edición

0003

Categorías

Ciencias básicas de la medicina preclínica
Farmacología
Farmacia y prescripción

Formulating Poorly Water Soluble Drugs (en Inglés)

Williams Iii, Robert O. ; Davis Jr, Daniel A. ; Miller, Dave A. (Autor) · Springer · Tapa Dura

Libro Nuevo

$ 383.47

$ 589.95

Ahorras: $ 206.48

35% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 23 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Formulating Poorly Water Soluble Drugs (en Inglés)"

The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.